Prostate Cancer - Results from #80

All that glitters is not gold: high uptake on PSMA PET in non-prostate cancers does not mean that treatment with [177Lu]Lu-PSMA-radioligand will be successful. October 21, 2024

Urologic oncology case volume among early career urologists: An analysis of certification data from the American board of urology between 2003 and 2019. October 20, 2024

Diet Quality, Dietary Inflammatory Potential, and Risk of Prostate Cancer Grade Reclassification. October 20, 2024

Molecular Correlates of Prostate Cancer Visibility on Multiparametric Magnetic Resonance Imaging: A Systematic Review. October 18, 2024

Targeted Prostate Health Checks, a novel system to identify men with prostate cancer-A pilot study. October 18, 2024

Revisiting HER2 in Prostate Cancer from an Inclusive Perspective: From Biomarkers to Omics. October 18, 2024

Sleep and health improvement programme (SHIP) for patients with prostate cancer and caregivers. October 18, 2024

Prostate-specific Membrane Antigen Positron Emission Tomography Before Reaching the Phoenix Criteria for Biochemical Recurrence of Prostate Cancer After Radiotherapy: Earlier Detection of Recurrences. October 18, 2024

Aerobic Physical Activity and Depression Among Patients With Cancer A Systematic Review and Meta-Analysis October 17, 2024

Investigating the pattern of prostate specific antigen screening among E-cigarette smokers within the behavioral risk factor surveillance system. October 17, 2024

General Obesity and Prostate Cancer in Relation to Abdominal Obesity and Ethnic Groups: A US Population-Based Cross-Sectional Study. October 17, 2024

Accuracy of the LaserSAFE technique for detecting positive surgical margins during robot-assisted radical prostatectomy: blind assessment and inter-rater agreement analysis. October 17, 2024

External Validation of a Previously Developed Deep Learning-based Prostate Lesion Detection Algorithm on Paired External and In-House Biparametric MRI Scans. October 17, 2024

Machine learning and explainable artificial intelligence to predict pathologic stage in men with localized prostate cancer. October 17, 2024

Phase 3 Trial of Stereotactic Body Radiotherapy in Localized Prostate Cancer. October 17, 2024

Copper-67 SAR-bisPSMA Updates October 16, 2024

Association between smoking and prostate cancer survivors' long-term quality of life and function: an analysis of the CEASAR (Comparative Effectiveness Analysis of Surgery and Radiation) study. October 16, 2024

Matched-pair analysis of mCRPC patients receiving 177Lu-labeled PSMA-targeted radioligand therapy in a 4-week versus 6-week treatment interval. October 16, 2024

Identification of a 5-gene signature panel for the prediction of prostate cancer progression. October 16, 2024

Enzalutamide in metastatic hormone-sensitive prostate cancer: A plain language summary of the ARCHES and ENZAMET follow-up studies. October 16, 2024

Page 5 of 1436